New biodegradable polymers for delivering multiple cancer drugs
Official title: Multifunctional Biodegradable Zwitterionic Polymer-Drug Conjugates for Multidrug Co-Delivery
Funded at State University of New York at Buffalo · NIH-11084287 · Data updated 2026-11-12
This study is looking at new ways to deliver cancer treatments using special biodegradable materials that can safely carry multiple drugs at once, aiming to make cancer therapy more effective and with fewer side effects for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of New York at Buffalo NIH-funded |
| Lab location | 1 site (Amherst, United States) |
| Project start | April 1, 2023 |
| Project end | March 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $492,141 |
| NIH project number | 5R01EB034306-03 |
| Project ID | NIH-11084287 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients undergoing treatment for cancer who may benefit from advanced drug delivery systems.
✕Less likely to help
Patients with non-cancerous conditions or those who are not currently receiving cancer treatment may not benefit from this research.
What this research studies
This research focuses on developing innovative biodegradable polymer-drug conjugates that can effectively deliver multiple cancer therapies simultaneously. By creating zwitterionic polymers that are both biocompatible and biodegradable, the project aims to overcome the limitations of traditional drug delivery systems that often cause side effects or are ineffective. The researchers will synthesize these new polymers and study how they interact with biological environments and cells to ensure they can deliver drugs safely and effectively. This approach could lead to improved treatment options for cancer patients.
Why it matters
Potential benefit: If successful, this research could provide a more effective and safer method for delivering cancer treatments, potentially improving patient outcomes.
How similar studies have gone: Other research has shown promise in using biodegradable polymers for drug delivery, indicating that this approach has potential for success.
Where this research is happening
-
State University of New York at Buffalo
Amherst, United States Active
Researchers
- Principal investigator: Cheng, Chong — State University of New York at Buffalo
- Study coordinator: Cheng, Chong
Related research
Other NIH-funded projects on the same topics.
-
Improving population health by studying reproductive health and development.
This study is looking at how different factors, like the environment and genetics, affect the health of pregnant women and people of reproductive age, with the goal of improving pregnancy outcomes and the health of children as they grow up.
-
How noise and hearing loss affect the first step of hearing in the brain
This NIH grant studies how noise and conductive hearing loss change the intimate connections between auditory nerves and brain cells, which could influence how we hear in noisy environments.
-
Programmable hydrogels to protect transplanted human OPCs in demyelinating disease
Aims to improve survival and integration of transplanted human oligodendrocyte precursor cells by using specially designed hydrogels to reduce cell death during delivery in demyelinating diseases like multiple sclerosis.
-
How a mouth bacterium might fuel gum disease and heart risk
A small study will look at how a bacterium in the mouth that makes a reactive chemical (methylglyoxal) could drive gum inflammation and changes in the mouth’s bacteria, possibly linking to heart disease.
-
New dual-acting treatments against tough Klebsiella pneumoniae infections
A new funding opportunity aims to develop therapies that both fight and disarm the dangerous Klebsiella pneumoniae bacteria, especially strains that resist many drugs, to help patients with serious infections.
-
Muscle health and aging in postmenopausal women
This NIH grant supports a study in older, postmenopausal women to understand how insulin and blood sugar relate to muscle loss over time and whether this differs by race/ethnicity.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.